MRGPRX2 and adverse drug reactions

BD McNeil - Frontiers in immunology, 2021 - frontiersin.org
Many adverse reactions to therapeutic drugs appear to be allergic in nature, and are thought
to be triggered by patient-specific Immunoglobulin E (IgE) antibodies that recognize the drug …

The role of PK/PD analysis in the development and evaluation of antimicrobials

A Rodríguez-Gascón, MÁ Solinís, A Isla - Pharmaceutics, 2021 - mdpi.com
Pharmacokinetic/pharmacodynamic (PK/PD) analysis has proved to be very useful to
establish rational dosage regimens of antimicrobial agents in human and veterinary …

[HTML][HTML] Ciprofloxacin

T Thai, BH Salisbury, PM Zito - StatPearls [internet], 2023 - ncbi.nlm.nih.gov
Ciprofloxacin - StatPearls - NCBI Bookshelf US flag An official website of the United States
government Here's how you know NIH NLM Logo Access keys NCBI Homepage MyNCBI …

Utilization of physiologically based pharmacokinetic modeling in clinical pharmacology and therapeutics: an overview

C Perry, G Davis, TM Conner, T Zhang - Current Pharmacology Reports, 2020 - Springer
The purpose of this review was to assess the advancement of applications for
physiologically based pharmacokinetic (PBPK) modeling in various therapeutic areas. We …

[HTML][HTML] Physiologically based pharmacokinetic (PBPK) modelling of oral drug absorption in older adults–an AGePOP review

C Demeester, D Robins, AE Edwina, J Tournoy… - European Journal of …, 2023 - Elsevier
The older population consisting of persons aged 65 years or older is the fastest-growing
population group and also the major consumer of pharmaceutical products. Due to the …

Physiologically based pharmacokinetic (PBPK) modeling of meloxicam in different CYP2C9 genotypes

CK Cho, HJ Park, P Kang, S Moon, YJ Lee… - Archives of Pharmacal …, 2021 - Springer
Meloxicam, a non-steroidal anti-inflammatory drug, is used for the treatment of rheumatoid
arthritis and osteoarthritis. Cytochrome P450 (CYP) 2C9 and CYP3A4 are major and minor …

Advanced in vivo prediction by introducing biphasic dissolution data into PBPK models

A Denninger, T Becker, U Westedt, KG Wagner - Pharmaceutics, 2023 - mdpi.com
Coupling biorelevant in vitro dissolution with in silico physiological-based pharmacokinetic
(PBPK) tools represents a promising method to describe and predict the in vivo performance …

Development of a physiologically based pharmacokinetic (PBPK) population model for Chinese elderly subjects

C Cui, JE Valerie Sia, S Tu, X Li, Z Dong… - British Journal of …, 2021 - Wiley Online Library
Aims This study aims to develop and verify a physiologically based pharmacokinetic (PBPK)
population model for the Chinese geriatric population in Simcyp. Methods Firstly …

Statistical and Artificial Intelligence-based Tools for Building Energy Prediction: A Systematic Literature Review

R Olu-Ajayi, H Alaka, F Sunmola… - IEEE Transactions on …, 2024 - ieeexplore.ieee.org
The application of statistical and artificial intelligence (AI) tools in building energy prediction
(BEP) is considered one of the most effective advances toward improving energy efficiency …

Development and evaluation of a physiologically based pharmacokinetic drug-disease model of propranolol for suggesting model informed dosing in liver cirrhosis …

MN Kalam, MF Rasool, F Alqahtani, I Imran… - Drug Design …, 2021 - Taylor & Francis
Aim The study was aimed to understand the underlying causes for the differences in
propranolol pharmacokinetics (PK) between healthy and cirrhosis populations by using a …